BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7900793)

  • 1. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans.
    Hickey MS; Carey JO; Azevedo JL; Houmard JA; Pories WJ; Israel RG; Dohm GL
    Am J Physiol; 1995 Mar; 268(3 Pt 1):E453-7. PubMed ID: 7900793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport.
    Ciaraldi TP; Molina JM; Olefsky JM
    J Clin Endocrinol Metab; 1991 Apr; 72(4):876-82. PubMed ID: 2005215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
    Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
    Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle.
    Azevedo JL; Carey JO; Pories WJ; Morris PG; Dohm GL
    Diabetes; 1995 Jun; 44(6):695-8. PubMed ID: 7789635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
    Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
    J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-I--stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM.
    Dohm GL; Elton CW; Raju MS; Mooney ND; DiMarchi R; Pories WJ; Flickinger EG; Atkinson SM; Caro JF
    Diabetes; 1990 Sep; 39(9):1028-32. PubMed ID: 2166697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.
    Goodyear LJ; Giorgino F; Sherman LA; Carey J; Smith RJ; Dohm GL
    J Clin Invest; 1995 May; 95(5):2195-204. PubMed ID: 7537758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.
    Friedman JE; Dohm GL; Leggett-Frazier N; Elton CW; Tapscott EB; Pories WP; Caro JF
    J Clin Invest; 1992 Feb; 89(2):701-5. PubMed ID: 1737857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport.
    Youngren JF; Maddux BA; Sasson S; Sbraccia P; Tapscott EB; Swanson MS; Dohm GL; Goldfine ID
    Diabetes; 1996 Oct; 45(10):1324-8. PubMed ID: 8826966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of glucose transporter in muscle from insulin-resistant patients.
    Dohm GL; Elton CW; Friedman JE; Pilch PF; Pories WJ; Atkinson SM; Caro JF
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E459-63. PubMed ID: 2003599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of in vitro sensitivities of glucose transport and antilipolysis to insulin in NIDDM.
    Yki-Järvinen H; Kubo K; Zawadzki J; Lillioja S; Young A; Abbott W; Foley JE
    Am J Physiol; 1987 Sep; 253(3 Pt 1):E300-4. PubMed ID: 3307452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus.
    Friedman JE; Caro JF; Pories WJ; Azevedo JL; Dohm GL
    Metabolism; 1994 Aug; 43(8):1047-54. PubMed ID: 8052146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
    Shao J; Catalano PM; Yamashita H; Ishizuka T; Friedman JE
    Am J Obstet Gynecol; 2000 Nov; 183(5):1263-70. PubMed ID: 11084576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.
    Dohm GL; Tapscott EB; Pories WJ; Dabbs DJ; Flickinger EG; Meelheim D; Fushiki T; Atkinson SM; Elton CW; Caro JF
    J Clin Invest; 1988 Aug; 82(2):486-94. PubMed ID: 3403714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.
    Stolic M; Russell A; Hutley L; Fielding G; Hay J; MacDonald G; Whitehead J; Prins J
    Int J Obes Relat Metab Disord; 2002 Jan; 26(1):17-23. PubMed ID: 11791142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
    Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
    J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.
    Utriainen T; Takala T; Luotolahti M; Rönnemaa T; Laine H; Ruotsalainen U; Haaparanta M; Nuutila P; Yki-Järvinen H
    Diabetologia; 1998 May; 41(5):555-9. PubMed ID: 9628273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
    Hollenbeck CB; Chen YD; Reaven GM
    Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training favors increased insulin-stimulated glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized study using FDG PET imaging.
    Reichkendler MH; Auerbach P; Rosenkilde M; Christensen AN; Holm S; Petersen MB; Lagerberg A; Larsson HB; Rostrup E; Mosbech TH; Sjödin A; Kjaer A; Ploug T; Hoejgaard L; Stallknecht B
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E496-506. PubMed ID: 23800880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.